Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Choriocarcinoma that develops in the placenta. It is the rarest form of gestational choriocarcinoma. Metastases to the mother and infant may occur.
Biomarker and diagnostic research for placental choriocarcinoma has been reported in the published literature.
1 clinical trial registered. Interventions under study include procedural interventions and biologic therapy. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
67 publications have been identified in PubMed for placental choriocarcinoma. Research spans Basic Science / Preclinical (52%), Review / Meta-Analysis (25%), and Case Report / Case Series (13%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 35 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 4:32 PM UTC
Research summaries | 17 | 25% |
Patient case studies | 9 | 13% |
Disease patterns and progression | 3 | 4% |
New treatment approaches | 2 | 3% |
Testing and diagnosis research | 1 | 1% |
Tsuchitani T (2026). [PMID: 42028857](https://pubmed.ncbi.nlm.nih.gov/42028857/). *J Physiol*. [Basic Science / Preclinical]
Wang T (2026). [PMID: 41808328](https://pubmed.ncbi.nlm.nih.gov/41808328/). *Ann Med*. [Review / Meta-Analysis]
Ogushi S (2026). [PMID: 41932659](https://pubmed.ncbi.nlm.nih.gov/41932659/). *Reprod Toxicol*. [Basic Science / Preclinical]
Mangla M (2026). [PMID: 41925035](https://pubmed.ncbi.nlm.nih.gov/41925035/). *Vasc Biol*. [Review / Meta-Analysis]
Shibata M (2026). [PMID: 41319368](https://pubmed.ncbi.nlm.nih.gov/41319368/). *Placenta*. [Gene Therapy / Novel Therapeutics]
Andersen LHJ (2026). [PMID: 42184357](https://pubmed.ncbi.nlm.nih.gov/42184357/). *J Immunol*. [Basic Science / Preclinical]
Rajput A (2026). [PMID: 42217332](https://pubmed.ncbi.nlm.nih.gov/42217332/). *Placenta*. [Basic Science / Preclinical]
Zeng G (2026). [PMID: 41161232](https://pubmed.ncbi.nlm.nih.gov/41161232/). *Tissue & cell*. [Basic Science / Preclinical]
Oliver-Pérez R (2026). [PMID: 41966975](https://pubmed.ncbi.nlm.nih.gov/41966975/). *International journal of gynecological cancer : official journal of the International Gynecological Cancer Society*. [Case Report / Case Series]
AlJulaih GH (2026). [PMID: 32965896](https://pubmed.ncbi.nlm.nih.gov/32965896/). *Unknown Journal*. [Review / Meta-Analysis]
AI-curated news mentioning placental choriocarcinoma
Updated Feb 25, 2026
A recent study published in PubMed discusses incidental intraplacental choriocarcinoma found during cases of intrauterine fetal demise. This research adds to the understanding of rare placental tumors and their implications in pregnancy.